Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Cobicistat |
Trade Name | Tybost |
Synonyms | GS 9350|Evotaz|Genvoya|Prezcobix|Rezolsta|Stribild |
Drug Descriptions |
Tybost (cobicistat) is an inhibitor of human cytochrome P450 3A (CYP3A), which potentially enhances exposure to other co-administered drugs (PMID: 24900196, PMID: 35933915). Tybost (cobicistat) is FDA approved to increase systemic exposure of atazanavir or darunavir in combination with other antiretroviral agents in the treatment of HIV-1 infection (FDA.gov). |
DrugClasses | |
CAS Registry Number | 1004316-88-4 |
NCIT ID | C97360 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cobicistat | Cobicistat | 0 | 0 |
Cobicistat + Gemcitabine + Nab-paclitaxel | Cobicistat Gemcitabine Nab-paclitaxel | 0 | 1 |
Cobicistat + Olaparib | Cobicistat Olaparib | 0 | 1 |
Cobicistat + Osimertinib | Cobicistat Osimertinib | 0 | 0 |
Cobicistat + PLX8394 | Cobicistat PLX8394 | 0 | 1 |